about
Hepatobiliary MR imaging with gadolinium-based contrast agentsHepatocellular adenoma: An update.Molecular pathogenesis of hepatic adenomas and its implications for surgical managementProgression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.Non-viral causes of hepatocellular carcinoma.Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma casesNon-viral factors contributing to hepatocellular carcinoma.Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma.Overview of hepatocellular adenoma in Japan.Management of hepatocellular adenoma: comparison of resection, embolization and observationHepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.Pathological Diagnosis of Hepatocellular Cellular Adenoma according to the Clinical Context.β-catenin activated hepatocellular adenoma.Behavior of hepatocellular adenoma on real-time low-mechanical index contrast-enhanced ultrasonography with a second-generation contrast agent.Malignant transformation of hepatocellular adenoma with bone marrow metaplasia arising in glycogen storage disease type I: A case report.Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinomaCan a decision-making model be justified in the management of hepatocellular adenoma?The value of immunophenotyping hepatocellular adenomas: consecutive resections at one UK centre.Benign solid tumors of the liver: management in the modern era.Enhancements in hepatobiliary imaging: the spectrum of gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid usages in hepatobiliary magnetic resonance imaging.Extrahepatic metastasis of hepatocellular carcinoma arising from a hepatic adenoma without concurrent intrahepatic recurrence.Screening the key genes of hepatocellular adenoma via microarray analysis of DNA expression and methylation profiles.Hepatocellular tumors: immunohistochemical analyses for classification and prognostication.Approach to Solid Liver Masses in the Cirrhotic Patient.Economic model of observation versus immediate resection of hepatic adenomas.Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas.Danazol-Induced Hepatocellular Carcinoma in a Patient with Hereditary Angioedema.A case of inflammatory hepatocellular adenoma displaying an unusual histological pattern.Frequency of TERT promoter mutations in primary tumors of the liver.Noncirrhotic hepatocellular carcinoma: derivation from hepatocellular adenoma? Clinicopathologic analysis.Q57642582
P2860
Q24631773-BE8F0229-3C66-49FB-9D64-244482B916DFQ26777656-0ECF387D-79B2-4C5D-AF38-81355EEE9589Q27027370-1AFB424B-64AA-4026-8DB6-7398B24FDD6AQ30375693-0B07D52B-CF69-4670-8665-C345FD4DD07BQ34041381-DDBCD091-5F20-4C09-815D-EF8AB37308F7Q34383286-9E2DF22F-1422-4184-AD34-80561F17B567Q34653639-87AAE08A-54E5-4FA6-A6BA-95E6122056EFQ34696921-7E8F2DBD-04FE-41DE-AA93-A7ABAE32EFD3Q36224975-947356EE-4751-4CD5-8A32-7AA1873F13A4Q36609392-DFB3277E-46DF-4EFB-B269-703BCFDA530DQ36668087-574A0B54-FACA-4B48-B3D8-7D7391E68DB8Q36838371-426CE638-0B08-4CF7-90A3-D1316D1BEB18Q36983551-27DE95E7-F140-4F55-9C17-24DA4BF630DAQ37331182-5326A06C-7A96-4E47-A4C2-759726D9B579Q37406790-59D361DB-343E-4473-9EB1-542257FACD1AQ37491718-1F0E2F78-F82A-46FE-8356-A19FCD681F49Q37958122-7D6C7DE6-D72F-457A-A498-83D3C9A89B56Q38047335-91C94482-1D37-4933-9527-FEE608473416Q38307901-A6CA6E91-0A08-4FE6-8FEB-0DE05FF7391CQ38844380-B06A5FB7-6108-4732-A440-2C5F19A35C3FQ41559563-31801D3D-9C15-49F5-A915-EDC82C73BFD8Q41701977-5F6970FA-81FF-4AC2-8FCF-34D5503803DCQ42114895-54EF20D7-665F-4652-8B4E-53C9FD0C18BAQ47095051-C87E00C0-4FFA-4AED-981C-E7724E68EC61Q47990394-3A98B278-D19E-4280-A5BA-70972D40F1B0Q48272046-EFA1B136-2851-4E1A-AC1A-4D549E7BC996Q52843292-C699F920-30CE-4776-8E5F-6B9DF47D1219Q53269977-7360EC74-5219-4ADC-BD68-03E2E2EAB86BQ54190292-1E5D383D-1D5A-43D9-8AB3-0F9A4583E50BQ55432565-16C18F66-B6EF-4C20-9E28-24A39F4C0428Q57642582-24914584-C861-4304-9D1E-B1C997771D92
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Malignant transformation of hepatic adenomas.
@en
Malignant transformation of hepatic adenomas.
@nl
type
label
Malignant transformation of hepatic adenomas.
@en
Malignant transformation of hepatic adenomas.
@nl
prefLabel
Malignant transformation of hepatic adenomas.
@en
Malignant transformation of hepatic adenomas.
@nl
P2093
P2860
P356
P1433
P1476
Malignant transformation of hepatic adenomas.
@en
P2093
John K Boitnott
Michael A Choti
Michael Torbenson
Perumal Vivekanandan
Shien T L Micchelli
P2860
P2888
P304
P356
10.1038/MODPATHOL.2008.8
P577
2008-02-01T00:00:00Z